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. . -. -. ; ! --. . < o f Me i c i n e , Texas Children's Hospital, Depts. of c o n s i s t primarily o f IgG and a r e l a r g e l y r e s t r i c t e d P e d i a t r i c s and Microbiology, Houston, TX, and Connaught Labs., t o the IgG2 s u b c l a s s . W e examined the ontogeny of the IgG Swiftwater, PA. subclass response t o pneumococcal polysaccharide type 3 t o The e f f i c a c y of PRP-0 vaccine i n young i n f a n t s has been determine i f the poor response of i n f a n t s t o immunization with documented i n previous s t u d i e s . W e now r e p o r t t h e response of polysaccharide antigens i s due t o a diminished capacity to form p a t i e n t s with IgG subclass d e f i c i e n c y (GSD) t o a s i n g l e t h i s subclass of a n t i b o d i e s . Sera from 33 p a t i e n t s aged 2 months immunization with PRP-0. P a t i e n t s with GSD ranging in age from 6 t o 25 years who had previously been shown t o respond t o t o 10 y e a r s h e r e given a s i n g l e i.m. dose of 20 pg PRP-D. Total polyvalent pneumococcal polysaccharide vaccine with IgG serum anti-pRp antibody l e v e l s were determined using a modified a n t i b o d i e s ( g r e a t e r than twofold r i s e i n post-immunization t i t e r ) Farr a s s a y and r a d i o l a b e l e d PRP. Four p a t i e n t s with GSO and no were assayed by ELISA using monoclonal a n t i b o d i e s s p e c i f i c f o r major abnormalities i n B-and T-cell s u b s e t s o r i n vitt-0 mitogen IgGl, IgG2, IgG3, o r IgG4. IgGl antibodies t o pneumococcal s t i m u l a t i o n had a mean pre-immunization anti-PRP level o f 1.61 polysaccharide type 3 were uniformly low i n a l l age groups. I n pg/ml which r o s e t o 22.6 pg/ml 3-4 weeks a f t e r i n u n i z a t i o n -The c o n t r a s t , IgG2 antibody a c t i v i t y was lowest in c h i l d r e n l e s s than mean i n c r e a s e i n anti-PRP f o r 3 p a t i e n t s with IgG2 d e f i c i e n c y was the age of 2 y e a r s (170+20 ng/ml), but rose progressively i n t h e 18.8 pg/ml. Two p a t i e n t s with IgA and IgG2 d e f i c i e n c y responded age group 2-5 y e a r s (215540 ng/ml), 5-10 years ( 3 3 0~3 0 ng/ml), with post-immunization anti-PRP l e v e l s of 10.8 and 40 ~g / m l . Both and over the age of 10 ( 3 9 0~3 0 nglml) ( d i f f e r e n c e s s i g n i f i c a n t a t o f t h e s e p a t i e n t s f a i l e d t o respond t o immunization with a p<.0005 by ANOVA). Since the prevention of i n f e c t i o n using a polyvalent pneumococcal pol ysaccharide (PS) vaccine. One P a t i e n t p u r i f i e d b a c t e r i a l polysaccharide vaccine appears t o depend on an with i s o l a t e d IgG3 d e f i c i e n c y responded normally t o d i p h t h e r i a adequate serum l e v e l o f IgG2 antibody, the delay i n the ontogeny and t e t a n u s toxoid, t o 3 of 4 pneumococcal ser0tYpeS t e s t e d , and of the IgG2 subclass e x p l a i n s the r e l a t i v e i n e f f e c t i v e n e s s of had a r i s e of anti-PRP antibody from 0.6 t o 28.4 ~g / m l . A f i f t h p u r i f i e d polysaccharide vaccines i n c h i l d r e n under the age o f 2 p a t i e n t with common v a r i a b l e immunodeficiency had no response t o years. Our f i n d i n g s a r e c o n s i s t e n t with the hypothesis t h a t immunization with any of t h e above vaccines. These data Suggest p u r i f i e d b a c t e r i a l capsular polysaccharide antigens t h a t p r o t e i n conjugate vaccines may lead t o e f f e c t i v e p r e f e r e n t i a l l y a c t i v a t e IgG2-cormnitted B c e l l clones a t a l l immunization of p a t i e n t s with d e f e c t i v e PS antigen processing.
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THE ROLE OF IgAl RHEUMATOID FACTOR (RF) I N THE FORMATION OF IgA-CONTAINING CIRCULATING IMMUNE COMPLEXES (CIC) I N HENOCH-SCHONLEIN PURPURA (HSP).
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(Spon. by Robert L. Chevalier), University of V i r g i n i a Medical Center, Department o f P e d i a t r i c s , C h a r l o t t e s v i l l e , VA.
Current evidence suggests t h a t CIC a r e involved i n t h e pathogenesis of HSP, and s e v e r a l s t u d i e s have demonstrated both IgA and IgO containing C I C i n p a t i e n t s w i t h HSP. Recent work from t h i s l a b o r a t o r y showed t h a t over 50% of c h i l d r e n w i t h HSP have IgA RF. The p r e s e n t s t u d y was performed t o i n v e s t i g a t e
t h e r o l e o f IgA RF i n t h e formation of IgA containing C I C i n HSP, and t o determine t h e s u b c l a s s composition of IgA RF. CIC were i s o l a t e d from t h e s e r a of 22 c h i l d r e n w i t h HSP and 1 3 c o n t r o l s by means of polyethylene g l y c o l (PEG) p r e c i p i t a t i o n . The percentage of I&, IgA, and IgM p r e c i p i t a t e d by PEG was s i g n i f i c a n t l y g r e a t e r i n HSP p a t i e n t s than c o n t r o l s (P<0.01). There was a s t r o n g c o r r e l a t i o n (rz.723, P<0.001) between t h e amount of I& and IgA i n t h e PEG p r e c i p i t a t e s from HSP p a t i e n t s , but not controls. HSP p a t i e n t s had s i g n i f i c a n t l y higher l e v e l s of IgA RF i n t h e i r serum (P<0.05) and i n t h e i r PEG p r e c i p i t a t e s (P<0.05) compared t o c o n t r o l s . PEG p r e c i p i t at i o n e l i m i n a t e d IgA RF a c t i v i t y from t h e serum of seven of e i g h t HSP p a t i e n t s t e s t e d ; IgA RF was recovered i n t h e PEG p r e c i p i t a t e s from a l l p a t i e n t s . Testing of HSP p a t i e n t s showed t h a t IgA1 was t h e predominant IgA s u b c l a s s of t h e serum IgA RF (P<0.02) and PEG p r e c i p i t a t e IgA RF (P<0.01).
These r e s u l t s suggest t h a t IgA RF is a c o n s t i t u e n t of IgA C I C i n HSP, and t h a t IgA RF is predominantly IgAl i n composition. 
f B K t i i n i a Medical Center, Department of P e d i a t r i c s , C h a r l o t t e s v i l l e , VA. Eleven neonates received blood from two H I V i n f e c t e d donors.
A l l developed l a b o r a t o r y and/or c l i n i c a l evidence o f H I V i n f e c t i o n , u s u a l l y i n t h e f i r s t year of l i f e . Nine of 11 had serum antibody t o H I V when t e s t e d between 9 and 16 months of age; two seronegative i n f a n t s were s e v e r e l y hypogammaglobulinemic when t e s t e d . Nine p a t i e n t s developed a v a r i e t y of i l l n e s s e s c h a r a c t e r i z e d by hepatosplenomegaly, lymphadenopathy, chronic d i a r r h e a , f a i l u r e t o t h r i v e , and thrombocytopenia. I n f e c t i o n s , i n c l u d i n g pneumonia, mucocutaneous c a n d i d i a s i s , and s e p s i s were a major s o u r c e of morbidity and m o r t a l i t y . Two c h i l d r e n have remained continuously asymptomatic. I n follow-up ranging from two t o f o u r years, f i v e p a t i e n t s have died, f o u r o t h e r s had HIV a s s o c i a t e d i l l n e s s e s , but recovered and a r e now healthy. A l l p a t i e n t s had immunologic a b n o r m a l i t i e s ; t h e most c o n s i s t e n t f i n d i n g was a decreased proportion of T-helper c e l l s . Three p a t i e n t s had panhypogammaglobulinemia. These i n f a n t s had s i g n i f i c a n t l y l o w e r numbers o f T-helper c e l l s compared t o p a t i e n t s w i t h normal o r increased serum immunog l o b u l i n c o n c e n t r a t i o n s (P-0.012).
We conclude t h a t exposure t o H I V v i a t r a n s f u s i o n i n t h e neonatal period r e s u l t s i n an extremely high r a t e of i n f e c t i o n w i t h s u b s t a n t i a l m o r t a l i t y and morbidity, but c l i n i c a l recovery occurs i n some p a t i e n t s . Second, hypogammaglobulinemia may be more common i n i n f a n t s w i t h H I V i n f e c t i o n than previously appreciated. T u f t s i n , one of the proposed parameters of s p l e n i c function, was u t i l i z e d a s a monitor of s p l e n i c imnunologic a c t i v i t y in a p a t i e n t who underwent splenectomy and autologus spleen implantation a t age of 30 hours a f t e r decapsulation and massive hemmorhage. S e r i a l t u f t s i n l e v e l s were obtained a t ages 3, 4 1/2, 6 , 13 and 26 months. T u f t s i n l e v e l s were measured b y E L I S A technique, normal l e v e l s a r e above 200 ng/ml.
Tuftsin l e v e l s were below 100 ng/ml a t the age of 3 and 4 1/2 nwnths, between 100
and 200 ng/ml a t 6 months and repeatedly above 200 ng/ml from age 13 months.
Normal t u f t s i n l e v e l s were measured only a t age 13 months o r more d e s p i t e the f a c t t h a t Technetium 99m scan demonstrated uptake a t the age of 6 months and blood smears from age one week did not show any Howell J o l l y bodies. A n t i b i o t i c prophylaxis was discontinued only a f t e r t u f t s i n l e v e l s became normal. Given previous r e p o r t s of increased i n f e c t i o n r i s k even in p a t i e n t s with docmented s p l e n i c t i s s u e p o s t autologus implantat i o n , t h i s case suggests t h a t t u f t s i n l e v e l s can be u t i l i z e d a s a more s p e c i f i c i n d i c a t o r of s p l e n i c a c t i v i t y and a s a guide f o r d i s c o n t i n u a t i o n of a n t i b i o t i c prophylaxis.
